SCR-LIP-000676 · Claim · machine-readable JSON →
Lymphatic dysfunction in lipedema may be more pronounced in severe disease or with longer disease duration.
General proposition consolidated from 5 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 5 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (5)
- Uncovering Lymphatic Transport Abnormalities in Patients with Primary Lipedema — Gould et al. (2019) ✓ verified — consistent · cross sectional · 2019 · reading confidence: moderate
“The mean TI was significantly greater for extremities with severe (stage 3/4) lipede”
In 19 lipedema patients, pathologic lymphatic transport in 63.2% of limbs; transport index higher in severe (stage 3/4) than mild/moderate disease (15.1 vs 9.7, p=0.049).
This cross-sectional study directly addresses lymphatic dysfunction in lipedema and its association with clinical staging, providing objective lymphoscintigraphic evidence that lymphatic transport abnormalities worsen with lipedema severity - Lymphatic function and anatomy in early stages of lipedema — Rasmussen et al. (2022) ✓ verified — consistent · cross sectional · 2022 · reading confidence: moderate
In early-stage lipedema, near-infrared fluorescence imaging showed dilated vessels and increased propulsion without dermal backflow; lymphatic failure absent early but likely contributes to lipolymphedema.
Pilot study with 20 participants addressing lymphatic anatomy and function in early lipedema; directly relevant to the question of progression to lymphedema and functional disability, but refines rather than simply supports or contradicts b - Non-contrast MR Lymphography of lipedema of the lower extremities — Cellina et al. (2020) ✓ verified — consistent · case series · 2020 · reading confidence: high
On non-contrast MR lymphography of 44 limbs, epifascial fluid was absent in pure lipedema but present in all lipolymphedema limbs (p<.001); dilated lymphatics 90.9% vs 18.2%.
Retrospective imaging study (n=22 patients) directly comparing MR lymphography findings between lipedema and lipolymphedema, identifying distinguishing features for differential diagnosis; small sample limits confidence. - Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipedema — Buso et al. (2021) ✓ verified — refining · cross sectional · 2021 · reading confidence: high
“O funcionamento linfático em pacientes com lipedema correlaciona-se com a duração dos sintomas, sugerindo que a velocidade do ICG nos linfáticos superficiais depende principalmente do tempo de evolução da doença, e não do grau de acúmulo de gordura ou do estadiamento. Não foram encontradas alteraçõe”
In 45 women, ICG lymphatic transit correlated with symptom duration (r=-0.469, p=0.037) rather than stage or fat accumulation; no major anatomical abnormalities.
The article applies lipedema type/stage classification to its cohort but focuses on ICG lymphographic assessment of lymphatic function, not on the diagnostic criteria or reliability of classification systems themselves; it notes that lympha - Update in the management of lipedema — FORNER-CORDERO et al. (2021) ✓ verified — refining · review · 2021 · reading confidence: moderate
“transporte linfático prejudicado em estágios precoces”
Review reports abnormal lymphoscintigraphic patterns and impaired lymphatic transport already in early lipedema stages.
The review addresses lymphatic dysfunction and clinical staging relevant to potential progression toward lymphedema, but as a narrative review it provides background/context rather than direct evidence quantifying progression to lymphedema
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000017